Anaergia Inc. (TSX:ANRG)
Canada flag Canada · Delayed Price · Currency is CAD
2.460
+0.060 (2.50%)
Jul 10, 2026, 4:00 PM EST

Anaergia Earnings Call Transcripts

Fiscal Year 2026

  • AGM 2026

    The meeting covered the presentation of 2025 financials, election of seven directors, and reappointment of auditors, with all proposals approved. No questions were raised during the Q&A session.

  • Revenue grew 122% year-over-year to CAD 55.2 million, with gross profit up 135% and positive adjusted EBITDA for the third consecutive quarter. Backlog reached CAD 265 million, and strategic milestones included entry into the HVO market and regulatory approval for the SoCal Biomethane facility.

Fiscal Year 2025

  • Record revenue and gross profit growth in 2025, with positive Adjusted EBITDA and a doubled revenue backlog. Strong commercial momentum, improved margins, and expanding global demand position the company for continued growth in 2026.

  • Q3 2025 marked a financial turnaround with revenue up 77% year-over-year, positive adjusted EBITDA, and a record $287 million backlog. Growth was driven by strong capital sales in Europe and North America, with margin expansion and operational efficiency supporting future outlook.

  • Q2 2025 saw revenue rise 36.8% year-over-year to $32.3 million, with gross margin up to 32.5% and backlog more than doubling since year-end. Expanded contracts in Europe and North America and disciplined execution drove improved profitability and a robust project pipeline.

  • Revenue for Q1 2025 was CAD 24.9 million, with a record CAD 200 million backlog, up 94% year-over-year. Margins in capital sales improved, net loss narrowed, and major contract wins in Italy and Asia support strong future growth.

Fiscal Year 2024

Fiscal Year 2023